Brain screening for high-risk metastatic breast cancer
Part of Brain & nervous system, Cancer clinical trials.
This study is looking at whether routine brain scans (MRI) at the time of diagnosis of metastatic breast cancer can help detect brain metastases early, even before they cause symptoms. It aims to understand how common brain metastases are in high-risk breast cancer and whether early detection can help guide treatment decisions. This may be relevant for people with certain types of breast cancer that have spread to other organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that has spread to other parts of the body (metastatic) and you have one of these types: HER2-positive, triple negative, or ER-positive that has progressed after at least two lines of treatment.
- If you have ER-positive disease, you must have tried a CDK4/6 inhibitor (like palbociclib, ribociclib, or abemaciclib) and have either more than two bone metastases or cancer that has spread to organs (visceral).
- You were diagnosed with metastatic breast cancer within the last 3 months.
- You do not have any symptoms of brain metastasis and have not had a brain MRI yet as part of this trial.
- You are eligible for Medicare (Australian health insurance).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to look for cancer that has spread to the brain in people with certain types of breast cancer, lung cancer, or melanoma. The goal is to find brain metastases early, when they may be easier to treat.
This study tests a new drug (SHR-A1811) combined with radiation therapy for breast cancer that has spread to the brain. The goal is to see if this combination can help control the brain tumors and possibly improve outcomes.
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
Hear when a new Brain Metastasases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.